Cancer Research Supercluster / NeoTREX^®

The Colorado State University Cancer Supercluster is a multidisciplinary alliance of researchers, economists and business experts working on innovative research and discovery in the area of cancer research. Cancer is a complex global problem that demands multidisciplinary approaches to make cutting edge discoveries that are of interest and importance to government, not-for-profit entities, and corporate and philanthropic partners locally, regionally, nationally and across the world. The Cancer Supercluster is built on the foundation of more than three decades of Colorado State excellence in cancer research currently funded by organizations such as NASA, the National Institutes of Health, the National Cancer Institute, Morris Animal Foundation and U.S. Department of Energy.

The cancer research effort at CSU comprises 77 scientists and scholars at the forefront of research from 5 colleges and 12 departments and 28 affiliate faculty members with over $20 million dollars in annual research support. Departments represented include the Colleges of Veterinary Medicine and Biomedical Sciences, Natural Sciences, Applied Human Sciences, Agricultural Sciences and Engineering.

This innovative model, unique university infrastructure, and its capabilities, such as a fully developed clinical trials program and tissue archiving programs, are optimally leveraged for partnering research and collaborations. Scholarly excellence in this extraordinary research environment fosters creativity in promoting product and policy development with potential for global impact. The goal of the Cancer Supercluster is to develop effective treatments and products in the fight against cancer and quickly move these advances into the marketplace to the people who need them through its enterprise arm NeoTREX.

NeoTREX is the first of its kind enterprise arm of the Cancer Supercluster created by CSU Ventures, a 501(c)(3) corporation which believes that rapidly bringing products to market is the most effective way to leverage university research for the benefit of companion animals and humans. This enterprise arm of the Cancer Supercluster advances emerging products by partnering with private and public sector organizations. Patents, licenses, partnerships and startup companies are the focus of this enterprise arm as specialists of both marketplace and university research work to translate discoveries into products. It includes a Chief Operating Officer, Chief Scientific Officer, Director of Business Development, Director of Outlicensing, and Colorado State University's Technology Transfer Office.

If you are interested in the Cancer Research Supercluster/NeoTREX please visit this website for more information: Cancer Research Supercluster/NeoTREX

NeoTREX^® / Cancer Supercluster Team